Childhood trauma and clinical high risk for psychosis.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
03 2019
Historique:
received: 03 02 2018
revised: 01 05 2018
accepted: 04 05 2018
pubmed: 22 5 2018
medline: 30 4 2020
entrez: 22 5 2018
Statut: ppublish

Résumé

As a risk factor for psychosis, childhood trauma rates are elevated in the clinical-high-risk (CHR) syndrome compared to the general population. However, it is unknown whether trauma is typically experienced in childhood or adolescence/young adulthood, whether it occurred prior to CHR syndrome onset, and how severe trauma relates to presenting symptoms. In this study, we examined the relationship of trauma history to symptoms and functioning in individuals diagnosed with the CHR syndrome on the Structured Interview for Psychosis-Risk Syndromes (N = 103). Trauma, defined as meeting the DSM-IV A1 criterion of actual or threatened death or injury, was assessed by semi-structured interview. A large proportion of CHR participants (61%) reported trauma exposure, including interpersonal trauma, trauma prior to CHR onset, and childhood trauma prior to age 12. Those with a trauma history (versus those without trauma) were rated as having more severe perceptual disturbances, general/affective symptoms and more impairment on the Global Assessment of Functioning Scale. The number of traumatic events correlated with more severe ratings in those three domains. Additionally, the number of interpersonal traumas was correlated with ratings of suspiciousness. Trauma was unrelated to specific measures of social and role functioning. A small proportion of CHR participants were diagnosed with formal PTSD (14%), which was unrelated to symptom severity or functioning. Thus, we demonstrate that trauma exposure is often early in life (before age 12), occurs prior to the onset of the CHR syndrome, and is related to both positive and affective symptoms.

Identifiants

pubmed: 29779964
pii: S0920-9964(18)30259-7
doi: 10.1016/j.schres.2018.05.003
pmc: PMC6939986
mid: NIHMS1063772
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-14

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH086618
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH076989
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH018261
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Schizophr Bull. 2007 May;33(3):688-702
pubmed: 17440198
Acta Psychiatr Scand. 2010 May;121(5):377-84
pubmed: 20199494
J Abnorm Psychol. 1977 Apr;86(2):103-26
pubmed: 858828
Psychol Med. 2015 Apr;45(6):1277-88
pubmed: 25273550
Early Interv Psychiatry. 2013 Nov;7(4):414-20
pubmed: 23343404
Front Psychiatry. 2017 Apr 20;8:55
pubmed: 28473776
Am J Psychiatry. 2016 Oct 1;173(10):980-988
pubmed: 27363508
Psychol Med. 2015 Dec;45(16):3453-65
pubmed: 26166153
Can J Psychiatry. 2013 Jan;58(1):44-51
pubmed: 23327756
J Abnorm Psychol. 2015 Nov;124(4):918-32
pubmed: 26301973
Psychol Med. 1997 Sep;27(5):1101-19
pubmed: 9300515
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Clin Psychol Rev. 2007 May;27(4):409-24
pubmed: 17222489
Acta Psychiatr Scand. 2011 Jan;123(1):28-35
pubmed: 20712824
Psychiatry Res. 2016 Feb 28;236:182-185
pubmed: 26795128
Schizophr Res. 2011 Jun;129(1):42-6
pubmed: 21511440
Front Psychiatry. 2017 Mar 06;8:33
pubmed: 28321193
J Nerv Ment Dis. 2010 Nov;198(11):813-9
pubmed: 21048472
Front Psychiatry. 2017 Nov 03;8:220
pubmed: 29163239
Schizophr Res. 2009 Mar;108(1-3):176-81
pubmed: 19174322
Early Interv Psychiatry. 2015 Feb;9(1):12-20
pubmed: 23802596
Schizophr Res. 2015 Feb;161(2-3):143-9
pubmed: 25499046
Nat Rev Neurosci. 2009 Jun;10(6):434-45
pubmed: 19401723
Biol Psychiatry. 2017 Jan 1;81(1):9-20
pubmed: 27720198
Am J Psychiatry. 2011 Jan;168(1):65-72
pubmed: 20952460
Front Psychol. 2017 Mar 14;8:341
pubmed: 28352239
Soc Psychiatry Psychiatr Epidemiol. 2016 Apr;51(4):497-503
pubmed: 26851943
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
Psychol Med. 2012 Dec;42(12):2475-84
pubmed: 22716897
Schizophr Res. 2015 Dec;169(1-3):199-203
pubmed: 26386899
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Psychiatry Res. 2016 Dec 30;246:776-782
pubmed: 27817908
Psychosis. 2012;4(3):203-212
pubmed: 23155365
Psychiatry Res. 2013 Nov 30;210(1):75-81
pubmed: 23871168
Psychol Rev. 1997 Oct;104(4):667-85
pubmed: 9337628
Schizophr Res. 2016 Aug;175(1-3):174-179
pubmed: 27107632

Auteurs

Rachel L Loewy (RL)

University of California, San Francisco, Department of Psychiatry, Weill Institute for Neurosciences, 401 Parnassus Ave., Box 0984-PAR, San Francisco, CA 94143-0984, United States. Electronic address: rachel.loewy@ucsf.edu.

Sarah Corey (S)

Partners HealthCare, 399 Revolution Drive, Somerville, MA 02145, United States.

Felix Amirfathi (F)

University of California, San Francisco, Department of Psychiatry, Weill Institute for Neurosciences, 401 Parnassus Ave., Box 0984-PAR, San Francisco, CA 94143-0984, United States.

Sawsan Dabit (S)

Posit Science Corporation, 160 Pine Street, Suite 200, San Francisco, CA 94111-5513, United States.

Daniel Fulford (D)

Department of Occupational Therapy and Rehabilitation Sciences, Boston University, 635 Commonwealth Ave., Boston, MA 02215, United States; Department of Psychological & Brain Sciences, Boston University, 635 Commonwealth Ave., Boston, MA 02215, United States.

Rahel Pearson (R)

University of Texas at Austin, Institute for Mental Health Research, Department of Psychology, 305 E. 23rd St Stop A9000, Austin, TX 78712, United States.

Jessica P Y Hua (JPY)

University of Missouri, Department of Psychological Sciences, 210 McAlester Hall, Columbia, MO 65211-2500, United States.

Danielle Schlosser (D)

University of California, San Francisco, Department of Psychiatry, Weill Institute for Neurosciences, 401 Parnassus Ave., Box 0984-PAR, San Francisco, CA 94143-0984, United States; Verily Life Sciences, 269 E Grand Ave, South San Francisco, CA 94080, United States.

Barbara K Stuart (BK)

University of California, San Francisco, Department of Psychiatry, Zuckerberg San Francisco General Hospital and Trauma Center, 1001 Potrero Avenue, Bldg 5, Room 7G42, San Francisco, CA 94110, United States.

Daniel H Mathalon (DH)

University of California, San Francisco, Department of Psychiatry, Weill Institute for Neurosciences, 401 Parnassus Ave., Box 0984-PAR, San Francisco, CA 94143-0984, United States; Mental Health Service, Veterans Affairs San Francisco Healthcare System, San Francisco, CA 94121, United States.

Sophia Vinogradov (S)

Department of Psychiatry, University of Minnesota Medical School, F282/2A West, 2450 Riverside Avenue, Minneapolis, MN 55454, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH